Ascendis Pharma A/S (ASND) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Mobile

donwloadimg

Moomoo Desktop

The next-gen workspace

Click to view more download content

Sign up/Log in

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist

137.290
-2.990-2.13%

Close Jan 7 16:00 ET

135.510
-1.780-1.30%

Pre 04:11 ET

8.21BMarket Cap-17.80P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
BenzingaJan 7 09:10 ET
Ascendis Pharma Initiated at Buy by UBS
Dow JonesJan 7 07:56 ET · Ratings
Ascendis Pharma Analyst Ratings
BenzingaJan 7 07:44 ET · Ratings
UBS Initiates Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $196
Moomoo NewsJan 7 06:31 ET · Ratings
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $203
Moomoo NewsJan 6 19:32 ET · Ratings
Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireJan 6 08:30 ET

Comments

Oct 9, 2024 12:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

Sep 19, 2024 08:28

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

Sep 5, 2024 08:46

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

Aug 21, 2024 02:00

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Aug 12, 2024 12:25

Nice curl! On watch for recovery. May swing.

$Ascendis Pharma A/S (ASND.US)$

1

Read more

US

Overall

No Data